Testing effectiveness (Phase 2)Study completedNCT05246618
What this trial is testing
FIH Phase I/IIa Trial Evaluating Safety of TUM012 to Minimize Ischemic Reperfusion Injury in Kidney Transplantation
Who this might be right for
Ischemia-reperfusion InjuryKidney Transplant; Complications
iCoat Medical AB 18